Winnipeg, Canada

Viventia Bio Inc.


USPTO Granted Patents = 8

% Expired Patents = 12.5



Forward Citations = 7

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Glen MacDonald (7 out of 16 patents)

silverMedal Jeannick Cizeau (6 out of 17 patents)

bronzeMedal Francina C Chahal (4 out of 10 patents)

4.  Nicholas Ronald Glover (3 out of 13 patents)

5.  Joycelyn Entwistle (3 out of 9 patents)

6.  Stephen Hurly (2 out of 2 patents)

7.  Arjune Premsukh (1 out of 2 patents)

8.  Shilpa Chooniedass (1 out of 1 patent)

9.  Adrian Schwartz Mittelman (1 out of 1 patent)

10.  Denis Bosc (1 out of 2 patents)

11.  Denis Georges Bosc (3 patents)

12.  Glen Christopher Macdonald (0 patent)

13.  Glen Christopher Macdonald (0 patent)


8 patents:

Company Overview
Viventia Bio Inc. is a biotechnology company focused on the development of novel cancer therapeutics. Leveraging cutting-edge research and technology, Viventia Bio is dedicated to discovering innovative treatments to improve patient outcomes in oncology. With a pipeline of promising drug candidates, the company aims to address unmet medical needs and make a meaningful impact in the fight against cancer.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#23 in Winnipeg

#1,878 in Canada

Winnipeg, CA
Winnipeg, Canada
Forward Citations = 7

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viventia Bio Inc.. Retrieved from https://idiyas.com/company/viventia-bio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…